Blauvelt, A.; Draelos, Z. D.; Gooderham, M.; Lain, E.; Moore, A. Y.; Papp, K. A.; Zirwas, M.; Krupa, D.; Burnett, P.; Berk, D. R.; Chu, D. H. Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial: Assessment of Pruritus. J of Skin 2023, 7, s226.